Our preliminary observations on the relationship of sleep and lumbar CSF acid monoamine metabolite levels suggested a greater decrease in lumbar CSF HVA as compared to 5HIAA following clinical doses of phenelzine in the presence of virtually total REM suppression. This report on nine psychiatric pat
โฆ LIBER โฆ
Lifetime monoamine oxidase inhibition and sleep
โ Scribed by Wallace B. Mendelson; Robert M. Cohen; Iain C. Campbell; Dennis L. Murphy; J. Christian Gillin; Richard Jed Wyatt
- Book ID
- 113219217
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 230 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0091-3057
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
REM sleep and central monoamine oxidase
โ
David J. Kupfer; Malcolm B. Bowers
๐
Article
๐
1972
๐
Springer
๐
English
โ 454 KB
Central monoamine oxidase inhibition and
โ
Malcolm Bowers Jr.; David J. Kupper
๐
Article
๐
1971
๐
Elsevier Science
๐
English
โ 202 KB
Anion inhibition of monoamine oxidase
โ
M.H. Van Woert; G.C. Cotzias
๐
Article
๐
1966
๐
Elsevier Science
๐
English
โ 640 KB
Does phentermine inhibit monoamine oxida
โ
Richard B Rothman
๐
Article
๐
1999
๐
The Lancet
๐
English
โ 62 KB
Does phentermine inhibit monoamine oxida
โ
Timothy J Maher; Ismail H Ulus; Richard J Wurtman
๐
Article
๐
1999
๐
The Lancet
๐
English
โ 80 KB
Neurotoxins and monoamine oxidase inhibi
โ
Prof. K. T. Finnegan
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 675 KB
Recent clinical studies suggest that selegiline (1.-deprenyl) is useful in retarding the progress of Parkinson's disease. an effect that may bc related to its inhibition of monoamine oxidase type B (MAO-B). Selegilinc is also reported to prevent the toxic effects of the norddrenergic neurotoxin, h~-